FSCN1 gene polymorphisms: biomarkers for the development and progression of breast cancer
2017 · Scientific Reports · 49 citations
https://doi.org/10.1038/s41598-017-16196-6
G
Guinv Hu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
36
Papers
479
Citations
13
h-index
15
i10-index
Guinv Hu is an academic researcher from Wenzhou Medical University. The author has contributed to research in topics: Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research & MicroRNA in disease regulation. The author has an h-index of 13, co-authored 31 publications.
ORCID: 0000-0003-4062-9658Papers by this author
worksEGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
2017 · Scientific Reports · 45 citations
https://doi.org/10.1038/s41598-017-15939-9
TAp63 suppress metastasis via miR-133b in colon cancer cells
2014 · British Journal of Cancer · 41 citations
https://doi.org/10.1038/bjc.2014.118
Downregulated METTL14 Expression Correlates with Breast Cancer Tumor Grade and Molecular Classification
2020 · BioMed Research International · 14 citations
https://doi.org/10.1155/2020/8823270
Clinicopathological characteristics and prognostic significance of casting-type calcifications in patients with invasive breast cancer presenting with microcalcification
2024 · Scientific Reports · 7 citations
https://doi.org/10.1038/s41598-024-64353-5
MFGE8 induces anti-PD-1 therapy resistance by promoting extracellular vesicle sorting of PD-L1
2025 · Cell Reports Medicine · 7 citations
https://doi.org/10.1016/j.xcrm.2024.101922
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat